HomeCompareYMAIF vs MRK

YMAIF vs MRK: Dividend Comparison 2026

YMAIF yields 3571.43% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YMAIF wins by $5.979924439482386e+28M in total portfolio value
10 years
YMAIF
YMAIF
● Live price
3571.43%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.979924439482386e+28M
Annual income
$59,796,028,008,637,910,000,000,000,000,000,000.00
Full YMAIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — YMAIF vs MRK

📍 YMAIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYMAIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YMAIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YMAIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YMAIF
Annual income on $10K today (after 15% tax)
$303,571.43/yr
After 10yr DRIP, annual income (after tax)
$50,826,623,807,342,220,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, YMAIF beats the other by $50,826,623,807,342,220,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YMAIF + MRK for your $10,000?

YMAIF: 50%MRK: 50%
100% MRK50/50100% YMAIF
Portfolio after 10yr
$2.989962219741193e+28M
Annual income
$29,898,014,004,318,953,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

YMAIF
No analyst data
Altman Z
0.6
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YMAIF buys
0
MRK buys
0
No recent congressional trades found for YMAIF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYMAIFMRK
Forward yield3571.43%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$5.979924439482386e+28M$56.8K
Annual income after 10y$59,796,028,008,637,910,000,000,000,000,000,000.00$9,798.13
Total dividends collected$5.9799033957262955e+28M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: YMAIF vs MRK ($10,000, DRIP)

YearYMAIF PortfolioYMAIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$724,986$714,285.71$11,206$366.19+$713.8KYMAIF
2$97,569,555$96,793,820.33$12,650$502.35+$97.56MYMAIF
3$24,453,264,589$24,348,865,165.06$14,407$694.19+$24453.25MYMAIF
4$11,432,535,259,976$11,406,370,266,865.75$16,585$967.82+$11432535.24MYMAIF
5$9,980,034,425,756,912$9,967,801,613,028,738.00$19,342$1,363.89+$9980034425.74MYMAIF
6$16,274,968,045,603,344,000$16,264,289,408,767,783,000.00$22,913$1,947.19+$16274968045603.32MYMAIF
7$49,593,178,330,323,120,000,000$49,575,764,114,514,330,000,000.00$27,662$2,823.89+$49593178330323120.00MYMAIF
8$282,422,335,598,598,200,000,000,000$282,369,270,897,784,800,000,000,000.00$34,159$4,173.35+$282422335598598225920.00MYMAIF
9$3,005,968,398,087,102,000,000,000,000,000$3,005,666,206,188,011,000,000,000,000,000.00$43,337$6,308.80+$3.005968398087102e+24MYMAIF
10$59,799,244,394,823,860,000,000,000,000,000,000$59,796,028,008,637,910,000,000,000,000,000,000.00$56,776$9,798.13+$5.979924439482386e+28MYMAIF

YMAIF vs MRK: Complete Analysis 2026

YMAIFStock

Yoma Strategic Holdings Ltd., an investment holding company, engages in the real estate, automotive and heavy equipment, consumer, financial, and investment businesses in Singapore, Myanmar, and the People's Republic of China. The company's Real Estate Development segment develops and sells land and properties. Its Real Estate Services segment provides project management, design, and estate management services, as well as property leasing services and operates golf estate. The company's Automotive & Heavy Equipment segment supplies and sells agriculture and construction equipment, passenger and commercial vehicles, and related parts, as well as offers maintenance services. Its Consumer segment engages in the operation of restaurants; bottling and distribution of beverages; food wholesale business; and provision of logistics services. The company's Financial Services segment provides vehicle financing; and invests in mobile financial services. Its Investments segment invests in the infrastructure, tourism, power agricultural, and other sectors, as well as leases investment properties. The company also engages in leasing automotive equipment. The company was formerly known as Sea View Hotel Limited. Yoma Strategic Holdings Ltd. was incorporated in 1962 and is based in Singapore.

Full YMAIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this YMAIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YMAIF vs SCHDYMAIF vs JEPIYMAIF vs OYMAIF vs KOYMAIF vs MAINYMAIF vs JNJYMAIF vs ABBVYMAIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.